CYTK

Cytokinetics, Incorporated

60.30 USD
-0.30 (-0.50%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cytokinetics, Incorporated stock is down -9.04% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 61.9% of the previous 20 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 1 PUT, 9 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 May 17:47 17 Jan, 2025 60.00 PUT 80 218
20 May 18:05 21 Jun, 2024 55.00 CALL 68 53
20 May 18:05 21 Jun, 2024 55.00 CALL 50 53
20 May 18:06 21 Jun, 2024 55.00 CALL 119 53
20 May 18:07 21 Jun, 2024 55.00 CALL 150 53
20 May 18:37 21 Jun, 2024 55.00 CALL 45 53
20 May 18:40 21 Jun, 2024 55.00 CALL 105 53
20 May 19:19 21 Jun, 2024 55.00 CALL 125 53
20 May 19:32 21 Jun, 2024 55.00 CALL 75 53
21 May 15:21 21 Jun, 2024 63.00 CALL 250 0

About Cytokinetics, Incorporated

Cytokinetics, Incorporated focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure.

  • JP Morgan
    Tue May 14, 13:24
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 14, 07:15
    buy
    confirm
  • Needham
    Tue May 14, 05:33
    buy
    confirm
  • HC Wainwright & Co.
    Thu May 9, 15:32
    buy
    confirm
  • JP Morgan
    Thu May 9, 14:24
    buy
    confirm
  • Oppenheimer
    Thu May 9, 12:46
    buy
    confirm
  • Needham
    Thu May 9, 09:42
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 8, 11:43
    buy
    confirm